Antonious Hazim

480 total citations
29 papers, 268 citations indexed

About

Antonious Hazim is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonious Hazim has authored 29 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonious Hazim's work include Radiomics and Machine Learning in Medical Imaging (5 papers), Histiocytic Disorders and Treatments (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Antonious Hazim is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (5 papers), Histiocytic Disorders and Treatments (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Antonious Hazim collaborates with scholars based in United States, United Kingdom and Vietnam. Antonious Hazim's co-authors include Xiaoling Song, Kyle Muir, Laura Beretta, Marion Peyressatre, Ying He, Do Young Kim, Vinay Prasad, Gordon Ruan, Karen L. Rech and N. Nora Bennani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Antonious Hazim

19 papers receiving 264 citations

Peers

Countries citing papers authored by Antonious Hazim

Since Specialization

Citations

This map shows the geographic impact of Antonious Hazim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonious Hazim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonious Hazim more than expected).

Fields of papers citing papers by Antonious Hazim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonious Hazim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonious Hazim. The network helps show where Antonious Hazim may publish in the future.

Co-authorship network of co-authors of Antonious Hazim

This figure shows the co-authorship network connecting the top 25 collaborators of Antonious Hazim. A scholar is included among the top collaborators of Antonious Hazim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonious Hazim. Antonious Hazim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis 2025 ·Cancer Immunology Immunotherapy ·Antonious Hazim, (unknown), Jacob Shreve, Gordon Ruan, (unknown), (unknown), (unknown), (unknown), (unknown), Lisa A. Kottschade, (unknown), (unknown), Tobias Peikert, Eric S. Edell, Konstantinos Leventakos, (unknown)	1
2	Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment 2025 ·npj Precision Oncology ·(unknown), John Paul Shen, Fernando J. López-Díaz, Alessandro Leal, Isa Mambetsariev, Kaushal Parikh, Antonious Hazim, Brian Woodward, (unknown), (unknown), (unknown), Vamsidhar Velcheti, Jonathan W. Riess, Aaron S. Mansfield, Ravi Salgia, Hatim Husain	0
3	Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer 2025 ·JCO Oncology Practice ·Antonious Hazim, Konstantinos Leventakos, Vinicius Ernani	0
4	Correlation of mesothelin (MSLN) expression measured by RNA sequencing (RNASeq) and immunohistochemistry (IHC) in MSLN-expressing tumors. 2025 ·Journal of Clinical Oncology ·J. Randolph Hecht, Patrick Grierson, Theodore H. Welling, Kristen Spencer, Antonious Hazim, Jong Chul Park, Matthew L. Ulrickson, Kedar Kirtane, Hemant S. Murthy, Sandip Pravin Patel, Jennifer M. Specht, Wen-Kai Weng, Marcela V. Maus, David G. Maloney, (unknown), Julian R. Molina, Armen Mardiros, Maria Pia Morelli, John S. Welch, Diane M. Simeone	0
5	EP.07C.16 Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy 2024 ·Journal of Thoracic Oncology ·Antonious Hazim, An Xiao, Aditi P. Singh, Ki Yong Chung, Pedro Reck dos Santos, (unknown), (unknown), Anastasios Dimou, Kaushal Parikh, (unknown), (unknown), (unknown), Julian R. Molina, Aaron S. Mansfield, (unknown)	0
6	Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis 2024 ·American Journal of Hematology ·Gordon Ruan, Saurabh Zanwar, Aishwarya Ravindran, (unknown), Jithma P. Abeykoon, Antonious Hazim, Jason R. Young, Mithun Vinod Shah, N. Nora Bennani, Liuyan Jiang, Diana Morlote, Karen L. Rech, Gaurav Goyal, Ronald S. Go	9
7	Automated FDG PET/CT radiomics for risk stratification in newly diagnosed diffuse large B‐cell lymphoma (DLBCL) 2023 ·Hematological Oncology ·Jacob Shreve, Antonious Hazim, Allison M. Bock, Joshua C. Pritchett, Matthew J. Maurer, (unknown), Moritz Binder, Thomas E. Witzig, (unknown), Grzegorz S. Nowakowski, Anne J. Novak, (unknown), James R. Cerhan, Thomas M. Habermann, Stephen M. Ansell, Jonas Paludo	0
8	Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide 2023 ·European Heart Journal Open ·Antonious Hazim, Lara F. Nhola, (unknown), Song Zhang, Nicole P. Sandhu, Amir Lerman, Charles L. Loprinzi, Kathryn J. Ruddy, Hector R. Villarraga, Bradley R. Lewis, Joerg Herrmann	1
9	Utilizing predictive modeling to identify patients at high risk of death from immune checkpoint inhibitor therapy-related pneumonitis. 2023 ·Journal of Clinical Oncology ·Antonious Hazim, Jacob Shreve, (unknown), Gordon Ruan, (unknown), (unknown), (unknown), Konstantinos Leventakos, (unknown)	1
10	Ophthalmologic Involvement in Adults with Histiocytic Disorders 2022 ·Ophthalmology ·Samantha A. Banks, M. Tariq Bhatti, Ronald S. Go, Jithma P. Abeykoon, (unknown), Antonious Hazim, Gaurav Goyal, Jason R. Young, Matthew J. Koster, Robert Vassallo, Jay H. Ryu, Caroline Davidge‐Pitts, Aishwarya Ravindran, Julio C. Sartori‐Valinotti, N. Nora Bennani, Mithun Vinod Shah, Karen L. Rech, James A. Garrity, W. Oliver Tobin	2
11	Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival 2021 ·American Journal of Hematology ·Antonious Hazim, Gordon Ruan, Marie Hu, Aishwarya Ravindran, Karen L. Rech, Jason R. Young, Christian W. Cox, Jithma P. Abeykoon, Caleb Scheckel, Robert Vassallo, Jay H. Ryu, W. Oliver Tobin, Matthew J. Koster, N. Nora Bennani, Mithun Vinod Shah, Gaurav Goyal, Ronald S. Go	10
12	A single‐institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting 2021 ·International Journal of Laboratory Hematology ·Antonious Hazim, Gordon Ruan, Ryan B. Khodadadi, Joshua P. Slusser, Ariela L. Marshall, Rajiv K. Pruthi	7
13	Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care 2021 ·European Journal of Cancer ·(unknown), Ahmed Hamad, Ciara C. O’Sullivan, Antonious Hazim, (unknown), (unknown), Anne Turnbull, J.F.R. Robertson, Matthew P. Goetz	25
14	28-Year-Old Man With an Enlarged Left Testicle 2021 ·Mayo Clinic Proceedings ·Mason Webb, Antonious Hazim, Tony Y. Chon	0
15	Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas 2021 ·Cancer Immunology Immunotherapy ·Antonious Hazim, Neil Majithia, Stephen J. Murphy, Dennis A. Wigle, Marie-Christine Aubry, Aaron S. Mansfield	3
16	Retrospective analysis of 578 inpatient dermatology consultations in hematology and hematopoietic stem cell transplant patients 2021 ·International Journal of Dermatology ·(unknown), Antonious Hazim, David A. Wetter, Alina G. Bridges, Michael Camilleri, Marian T. McEvoy, Rokea A. el‐Azhary, Mark D. P. Davis, Julio C. Sartori‐Valinotti	0
17	Peripheral endothelial function changes during HER2-directed therapy differ based on whether or not a patient receives anthracycline. 2020 ·Journal of Clinical Oncology ·Antonious Hazim, Lara F. Nhola, Hector R. Villarraga, Shruti Patel, Nicole P. Sandhu, Amir Lerman, Charles L. Loprinzi, Kathryn J. Ruddy, Joerg Herrmann	1
18	A pooled analysis of published, basket trials in cancer medicine 2018 ·European Journal of Cancer ·Antonious Hazim, Vinay Prasad	18
19	Disseminated nocardiosis with infective endocarditis of a transplanted heart 2018 ·BMJ Case Reports ·Antonious Hazim, (unknown)	8
20	Proteomic and Lipidomic Signatures of Lipid Metabolism in NASH-Associated Hepatocellular Carcinoma 2013 ·Cancer Research ·Kyle Muir, Antonious Hazim, Ying He, Marion Peyressatre, Do Young Kim, Xiaoling Song, Laura Beretta	134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact